Graphene oxide improves postoperative cognitive dysfunction by maximally alleviating amyloid beta burden in mice

Rationale: Graphene oxide (GO) based nanomaterials have shown potential for the diagnosis and treatment of amyloid-β (Aβ)-related diseases, mainly on Alzheimer's disease (AD). However, these nanomaterials have limitations. How GO is beneficial to eliminate Aβ burden, and its physiological funct...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jiqian, Zhu, Shasha, Jin, Peipei, Huang, Yuting, Dai, Qingqing, Zhu, Qianyun, Wei, Pengfei, Yang, Zhilai, Zhang, Lei, Liu, Hu, Xu, Guanghong, Chen, Lijian, Gu, Erwei, Zhang, Yunjiao, Wen, Longping, Liu, Xuesheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667672/
https://www.ncbi.nlm.nih.gov/pubmed/33204319
http://dx.doi.org/10.7150/thno.50616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667672/
https://www.ncbi.nlm.nih.gov/pubmed/33204319
http://dx.doi.org/10.7150/thno.50616

Ejemplares similares